Results 231 to 240 of about 775,670 (354)
In this retrospective cohort of 3487 patients with CRC, history of CCY was associated with significantly worse prognosis in patients with proximal CRC but not in those with distal CRC. This differential prognostic impact showed a statistically significant interaction between tumor location and history of CCY and remained robust after PSM.
Masashi Tsunematsu +9 more
wiley +1 more source
Targeting cancer expressed EGFR with a humanized monoclonal antibody. [PDF]
Costa TGF +7 more
europepmc +1 more source
Exosomes are emerging as powerful biomarkers for disease diagnosis and monitoring. This review highlights the integration of surface‐enhanced Raman spectroscopy with artificial intelligence to enhance molecular fingerprinting of exosomes. Machine learning and deep learning techniques improve spectral interpretation, enabling accurate classification of ...
Munevver Akdeniz +2 more
wiley +1 more source
Quantitative Mapping of Nanoscale EGFR-Grb2 Assemblies by DNA-PAINT. [PDF]
Kaminer A +4 more
europepmc +1 more source
ABSTRACT Renal impairment (RI), defined as estimated glomerular filtration rate less than 60 mL/min with or without the need for dialysis, is a frequent and severe complication in patients with relapsed/refractory multiple myeloma (RRMM), as it can affect patient prognosis, drug metabolism and treatment options.
Ioannis Ntanasis‐Stathopoulos +7 more
wiley +1 more source
Natural compounds for non-small cell lung cancer treatment: focus on the EGFR signaling pathway. [PDF]
Ye B, Xiao Q.
europepmc +1 more source
IMpower151: is this the final blow to PD-(L)1 inhibitors in metastatic, <i>EGFR</i>-mutant non-small-cell lung cancer? [PDF]
van Beusekom SAL +2 more
europepmc +1 more source
Epidermal growth factor receptor expression analysis in chemotherapy-naive patients with advanced non-small-cell lung cancer treated with gefitinib or placebo in combination with platinum-based chemotherapy [PDF]
Abderrahim Fandi +38 more
core +1 more source
Accelerated bone loss increases osteoporosis and fracture risk in moderate to severe chronic kidney disease. [PDF]
Unwanatham N +7 more
europepmc +1 more source

